Performance Proof of Product Developed to Detect Abnormal Vaginal pH

Status Withdrawn

Clinical Trial Summary

This study was designed to validate the color appearance on the NORMA-SENSE gen 3 when comes into contact with vaginal secretions having an elevated pH level

Clinical Trial Description

This study was designed to validate the color appearance on the NORMA-SENSE gen 3. The NORMA-SENSE gen 3 changes color when worn by the user and comes into contact with vaginal secretions having an elevated pH level, without false positives due to urine remains or incontinence. The study will also asses the physical comfort in using NORMA-SENSE gen 3 and the result reading clarity which includes the ability to visualize and interpret the NORMA-SENSE gen 3 results. ;

Study Design

Related Conditions & MeSH terms

Vaginal Infection

Clinical Trial Details

NCT number	NCT01542606
Study type	Interventional
Source	Common Sense
Contact
Status	Withdrawn
Phase	N/A
Start date	March 2019
Completion date	December 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00324246` - Feasibility Study of the NEW NORMA-SENSE	Phase 3
Recruiting	`NCT05021315` - Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection	Phase 3
Not yet recruiting	`NCT05997160` - Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
Recruiting	`NCT05557318` - Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge	N/A
Completed	`NCT05044156` - Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
Completed	`NCT00694928` - Vaginal Infection Study 2	Phase 3
Not yet recruiting	`NCT05590195` - Effect of PreforPro® on Urinary and Vaginal Health	Phase 3
Completed	`NCT03898726` - Laparoscopic Versus Transvaginal Cuff Closure	N/A
Not yet recruiting	`NCT05806879` - Impact of Maternity Napkins on the Incidence of Vaginal Infections in the Post-partum Period	N/A
Completed	`NCT02308033` - Multi-Center Study of New Medications to Treat Vaginal Infections	Phase 3
Completed	`NCT02308046` - Multi-Center Study of New Medications to Treat Vaginal Infections	Phase 3
Completed	`NCT02308007` - Multi-Center Study of New Medications to Treat Vaginal Infections	Phase 3
Completed	`NCT01599416` - Influence of U-relax on Vaginal Health Promotion and HPV DNA Test Change From Positive to Negative	N/A
Recruiting	`NCT04719754` - Epidemiology of Abnormal Vaginal Discharge During Pregnancy
Completed	`NCT03008421` - Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy	N/A
Completed	`NCT03261804` - Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users
Terminated	`NCT05788991` - Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis	Phase 4
Completed	`NCT01843166` - Vaginal Estrogen With Pessary Treatment	N/A
Not yet recruiting	`NCT03532464` - Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection	Phase 4
Completed	`NCT01055106` - Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis	Phase 2